Table 2.
Surgical cohort: Clinical and Biomarker Details
| Specifics | R0 | R1 | R2 |
|---|---|---|---|
| No. | 102 | 29 | 22 |
| Age: median (range) | 59 (27-84) | 50 (26-85) | 60 (19-74) |
| Gender: M/F | 49/53 | 15/14 | 12/10 |
| Sites: | |||
| Lung | 26 | 1 | 0 |
| Pancreas | 45 | 7 | 5 |
| Small Bowel | 29 | 16 | 17 |
| Appendix | 0 | 1 | 1 |
| Stomach | 2 | 1 | 0 |
| Duodenum | 0 | 2 | 2 |
| Grade: | |||
| G1 | 40 | 19 | 17 |
| G2 | 32 | 10 | 5 |
| G3 | 3* | 0 | 0 |
| AC | 9 | 1 | 0 |
| TC | 17 | 0 | 0 |
| Staging | |||
| T | |||
| 1 | 38 | 0 | 0 |
| 2 | 34 | 16 | 5 |
| 3 | 20 | 13 | 11 |
| 4 | 10 | 0 | 6 |
| N | |||
| 0 | 55 | 7 | 0 |
| 1 | 44 | 22 | 22 |
| x | 3** | 0 | 0 |
| M | |||
| 0 | 98 | 18 | 10 |
| 1 | 4 | 11 | 12 |
| NETest (D0) Median (range)* | 67 (27-100) | 87 (40-100) | 87 (33-100) |
| NETest. No. positive (%) * | 102 (100%) | 29 (100%) | 22 (100%) |
| CgA (D0) Median (range)** | 55 (16-1158) | 67 (35-156) | 75 (40-158) |
| CgA: No. positive (%) ** | 18 (22%) | 2 (18%) | 3 (33%) |
*
Measured in Cohort 1
**
Measured in Cohort 2